Skip to main content
OpenTrials

Clinical trial condition

Chronic Myelomonocytic Leukemia

Explore clinical trials studying Chronic Myelomonocytic Leukemia. Study availability and eligibility vary by location and protocol.

191 public trials 39 recruiting studies
Refine in advanced search Browse all conditions

Chronic Myelomonocytic Leukemia trial results

Completed

Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)

NCT01736683

Conditions
Anemia, Bone Marrow Diseases, Chronic Disease, +16 more
Locations
  • Rocky Mountain Cancer Center-Midtown Denver, Colorado, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Dana-Farber / Harvard Cancer Institute Boston, Massachusetts, United States
View all 20 locations
View Trial Details
Completed

Ibrutinib and Azacitidine for Treatment of Higher Risk Myelodysplastic Syndrome

NCT02553941

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelomonocytic Leukemia, +15 more
Locations
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of California San Diego San Diego, California, United States
View Trial Details
Completed

Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid Neoplasms

NCT03072043

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +17 more
Locations
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Weill Medical College of Cornell University New York, United States
View Trial Details
Completed

Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia

NCT00860574

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +50 more
Locations
  • University of Colorado Denver, Colorado, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Phase II Part 2 Expansion of Oral Rigosertib in Combination With Azacitidine

NCT01926587

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +15 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Duarte, California, United States
  • Desert Hematology Oncology Medical Group, Inc. Rancho Mirage, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
View all 13 locations
View Trial Details

Related conditions